REGENXBIO-FDA to reverse rejection of Regenxbio's rare-disease drug, WSJ reports

FDA to reverse rejection of Regenxbio's rare-disease drug, WSJ reports

公司动态 - 美国食品药品监督管理局将撤销其早前对Regenxbio公司一款罕见病疗法的拒绝决定[1] 行业监管 - 监管机构对生物技术公司产品审评态度出现转变[1]

REGENXBIO-FDA to reverse rejection of Regenxbio's rare-disease drug, WSJ reports - Reportify